文献速递细菌感染、耐药与抗菌药物医院感染防控

新入住护理机构患者多重耐药菌的纵向评估:对不断变化人群的启示

Longitudinal Assessment of Multidrug-Resistant Organisms in Newly Admitted Nursing Facility Patients: Implications for an Evolving Population.
PubMed 文献 · Clin Infect Dis · 2018-01-01

在密歇根东南部6家护理机构开展前瞻性纵向队列研究,纳入651例新入住患者,入组时56.8%定植多重耐药菌,出院时56.4%仍定植,住院期间获得新多重耐药菌的每1000患者日发生率耐甲氧西林金黄色葡萄球菌为3.4、耐万古霉素肠球菌为8.2、耐药革兰阴性杆菌为13.6。

要点

  • 新入住护理机构患者入组时多重耐药菌定植率为56.8%,出院时为56.4%。
  • 入组时定植风险因素包括住院超过14天、功能障碍、抗生素使用或器械使用。
  • 住院期间获得新多重耐药菌的每1000患者日发生率:耐甲氧西林金黄色葡萄球菌3.4、耐万古霉素肠球菌8.2、耐药革兰阴性杆菌13.6。

核心结论

  • 短期入住护理机构的患者在入院前后及出院时多重耐药菌定植率均较高,可能成为其他医疗环境中传播的储库。
  • 未来减少多重耐药菌的干预措施应特别针对这一人群。

研究设计与样本

  • 前瞻性纵向队列研究,纳入密歇根东南部6家护理机构的新入住患者,在入组时、第14天和第30天及此后每月至多6个月对多个解剖部位进行主动微生物监测。
  • 共纳入651例患者,收集7526份样本,完成1629次访视,平均每例随访29天。
  • 近全部参与者因急性后期照护入住(95%)。

主要发现

  • 入组时56.8%定植多重耐药菌:耐甲氧西林金黄色葡萄球菌16.1%、耐万古霉素肠球菌33.2%、耐药革兰阴性杆菌32.0%。
  • 入组时定植风险因素包括住院超过14天、功能障碍、抗生素使用或器械使用。
  • 住院期间获得新多重耐药菌的每1000患者日发生率:耐甲氧西林金黄色葡萄球菌3.4、耐万古霉素肠球菌8.2、耐药革兰阴性杆菌13.6。
  • 出院时多重耐药菌定植率为56.4%:耐甲氧西林金黄色葡萄球菌18.4%、耐万古霉素肠球菌30.3%、耐药革兰阴性杆菌33.6%。

临床怎么用

  • 作者认为,未来减少多重耐药菌的干预措施应特别针对短期入住护理机构的人群。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The spread of multidrug-resistant organisms (MDROs) is a global concern, and much about transmission in healthcare systems remains unknown. To reduce hospital stays, nursing facilities (NFs) have increasingly assumed care of post-acute populations. We estimate the prevalence of MDRO colonization in NF patients on enrollment and discharge to community settings, risk factors for colonization, and rates of acquiring MDROs during the stay. METHODS: We conducted a prospective, longitudinal cohort study of newly admitted patients in 6 NFs in southeast Michigan using active microbial surveillance of multiple anatomic sites sampled at enrollment, days 14 and 30, and monthly thereafter for up to 6 months. RESULTS: We enrolled 651 patients and collected 7526 samples over 1629 visits, with an average of 29 days of follow-up per participant. Nearly all participants were admitted for post-acute care (95%). More than half (56.8%) were colonized with MDROs at enrollment: methicillin-resistant Staphylococcus aureus (MRSA), 16.1%; vancomycin-resistant enterococci (VRE), 33.2%; and resistant gram-negative bacilli (R-GNB), 32.0%. Risk factors for colonization at enrollment included prolonged hospitalization (>14 days), functional disability, antibiotic use, or device use. Rates per 1000 patient-days of acquiring a new MDRO were MRSA, 3.4; VRE, 8.2; and R-GNB, 13.6. MDRO colonization at discharge was similar to that at enrollment (56.4%): MRSA, 18.4%; VRE, 30.3%; and R-GNB, 33.6%. CONCLUSIONS: Short-stay NF patients exhibit a high prevalence of MDROs near the time of admission, as well as at discharge, and may serve as a reservoir for spread in other healthcare settings. Future interventions to reduce MDROs should specifically target this population.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mody L, Foxman B, Bradley S, et al. Longitudinal Assessment of Multidrug-Resistant Organisms in Newly Admitted Nursing Facility Patients: Implications for an Evolving Population. Clin Infect Dis. 2018. PMID: 29635360. doi:10.1093/cid/ciy194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。